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Abstract   
This study describes the preparation of free films of zein with and without acetylated 
high amylose maize starch (HAS) and their corresponding coated tablets as a novel 
approach to colonic drug delivery. We hypothesise that the embedding of a digestible 
starch component within the inert zein would allow the film to remain intact until the 
large intestine is reached. Free films of zein alone and starch/zein were prepared and 
characterised. SEM and AFM images of film surface showed that films were 
morphologically inhomogeneous, particularly at lower HAS/Zein ratios; however, 
nanothermal analysis data suggested that these differences in appearance within the 
same film are not compositional differences, i.e. the systems are not phase-separated. 
Moreover, FT-IR could detect no molecular interaction between the two polymers. 
Paracetamol tablets were coated with HAS/Zein aqueous based coatings of different 
compositions to a TWG of 20%. Drug release from zein alone and 1:5 HAS/Zein 
coated tablets under upper gastrointestinal conditions (pH 1.2, pH 6.8 with pepsin and 
pancreatin included) was very similar (for example approximately 12% and 14% of the 
drug was released, respectively, after 6 hours in a sequential in vitro test), suggesting 
that release in this region is limited and is not influenced by the presence of HAS in 
the ratio to zein under study. Studies using an in vitro colon model showed that under 
simulated colonic conditions, the drug release was significantly (p < 0.05) more rapid 
from 1:5 HAS/Zein, compared to the zein alone coating formulation. These data 
therefore support the potential use of zein-starch mixed films for colonic targeting 
purposes.    
  
 
1. Introduction 
Zein is the major storage protein of corn (Shukla and Cheryan, 2001), and constitutes 
44-79% of the endospermic protein content (Lawton, 2002). It is composed of  a 
mixture of different peptides that can be classified on the basis of their solubility and 
molecular weight into α (19 and 22 kDa), β (17-18 kDa), γ (16 and 27 kDa) and δ (10 
kDa) zeins (Esen, 1986). Among these, α-Zein accounts for 75-85% of the total zein 
and γ-zein is the next most abundant fraction and accounts for approximately 20% of 
the total. Zein is particularly rich in hydrophobic amino acids, but deficient in polar or 
ionisable amino acids (Gianazza et al., 1977; Righetti et al., 1977; Shukla and 
Cheryan, 2001); it is biodegradable and biocompatible (Dong et al., 2004) and has 
generally recognized as safe (GRAS) status. Based on its amino acid constitution, zein 
is recognized for being soluble in aqueous alcohol solutions but not in water (Swallen, 
1941). Indeed, its ability to form tough, glossy and hydrophobic coatings has been 
widely explored in food industry (Bai et al., 2003; Gennadios and Weller, 1990; Weller 
et al., 1998), while it has also been investigated for its potential use as a 
pharmaceutical excipient in encapsulation (Katayama and Kanke, 1992; Wang et al., 
2005) and coating processes (Beck et al., 1996; O’Donnell et al., 1997; Winters and 
Deardorff, 1958). For an overview on the uses of zein as an excipient for oral solid 
dosage forms, readers are referred to Berardi et al. (2018). 
Here we investigate the potential use of zein as a colonic delivery excipient. There has 
been considerable interest in colon targeting as this region of the gastrointestinal tract 
can be liable to many pathological conditions such as Crohn’s disease, ulcerative 
colitis and carcinomas. Colon-specific drug delivery may not only treat local disorders 
but may also reduce the administered doses and associated systemic side effects 
(Leopold, 2001). Colonic delivery of bioactives is also valuable for manipulation of the 
gut microbiota which is now known to play a critical role in our health and disease. 
Such delivery can be achieved by using polymeric coatings that are resistant to 
digestion in the upper gastrointestinal tract (GIT) yet are selectively degraded by the 
colonic microbiota (Basit, 2005). The use of naturally available polysaccharides, such 
as glassy amylose (McConnell et al., 2007; Siew et al., 2004), high amylose maize 
starch (Freire et al., 2010, 2009b), starch derivatives (Karrout et al., 2011, 2010, 2009),  
chitosan (Fan et al., 2009; He et al., 2009) and pectin (He et al., 2008; Wakerly et al., 
1997) has been reported for this application. However, these materials are hydrophilic 
  
 
in nature, which makes them either soluble or swellable in aqueous gastrointestinal 
environments, potentially resulting in drug release prior to the target region being 
reached by the dosage form. To limit this problem, these excipients have been mixed 
with water-insoluble polymers, such as ethyl cellulose, as reported by Liu et al. (2003) 
and Freire et al. (2009a, 2009b). Thus, it has been suggested that the water-insoluble 
zein could represent a valuable alternative to ethyl cellulose as a film-forming polymer 
for colonic delivery (Liu et al, 2006; Tang et al, 2015).  
This study aims to demonstrate the feasibility of using zein and high amylose 
starch/zein mixed coatings in colon-targetted drug delivery systems via assessment 
of their resistance to release in the upper GI tract. It has been found that heat treatment 
of high amylose starch generates a retrograded form that is more resistant to 
pancreatic α-amylases, yet susceptible to those present in the colon (Freire et al., 
2009a). In this study, free films of heat treated acetylated high amylose maize starch 
(HAS) and zein were prepared and characterized using a range of techniques 
including scanning electron microscopy (SEM), atomic force microscopy (AFM), nano-
thermal analysis (n-TA), and Fourier-transform infrared (FT-IR). In particular, the 
miscibility of the films is assessed as this is integral to the release properties.  
Paracetamol-loaded tablets were film coated with zein alone and HAS/zein aqueous 
dispersions and the drug release was assessed in simulated gastric and intestinal 
fluids with pepsin and pancreatin enzymes, respectively. In this manner it is intended 
that the ability of zein films to prevent or reduce drug release within the upper intestinal 
tract will be evaluated. Finally, drug release was assessed under simulated colonic 
conditions using a batch culture fermentation system, inoculated with human faecal 
bacteria.   
 
2. Materials and Methods 
2.1 Materials 
Zein from maize (Z3625) was obtained from Sigma-Aldrich (Germany) and used as 
received. This product was plasticized with polyethylene glycol 400 (Sigma Aldrich, 
UK). Acetylated high amylose maize starch (HAS) with a minimum degree of 
substitution (DS) of 0.06 was obtained from Roquette (Italy) and used as received. 
The amylose content of this starch is 51%.  
  
 
The model drug, paracetamol was obtained from Alfa Aesar (UK) and was used as 
received. Avicel PH 301 was obtained from FMC BioPolymer (UK). Anhydrous calcium 
phosphate dibasic of 97% purity was purchased from Acros Organics (USA). 
Polyvinylpyrrolidone K30 (PVP K30) and magnesium stearate were purchased from 
Aldrich (UK). Partially Gelatinized Starch (Pre-gelatinised starch) was purchased from 
Colorcon (UK) as the grade Starch 1500. All excipients were used as received. Pepsin 
from porcine gastric mucosa and pancreatin from porcine pancreas were supplied by 
Sigma (UK). 
2.2 Preparation of Zein and Starch–Zein Aqueous Dispersions 
Aqueous zein dispersions (10% w/w) were prepared by a precipitation method 
described by Li et al. (Li et al., 2010). The dispersion was plasticized with 30% (w/w) 
polyethylene glycol 400 (PEG 400) corresponding to the dry weight of zein. In order to 
prepare starch-zein dispersions, an aqueous dispersion of acetylated high amylose 
maize starch (HAS) was prepared by dispersing 3 g of HAS in 20 mL water, and 
heating to 80 ± 5 ˚C for 30 minutes, based on the method proposed by Freire et al. 
(Freire et al., 2009a). The HAS dispersion was allowed to cool down and then mixed 
with the pre-plasticized aqueous zein dispersion. Mixing using a magnetic stirrer was 
continued overnight to ensure complete dispersion of the two polymers. HAS–Zein 
dispersions were prepared in 1:3, 1:5 and 1:7 ratios, corresponding to the dry weight 
of both polymers. Zein (alone) dispersions were prepared by admixing the pre-
plasticized aqueous zein dispersion with distilled water (same volume as used for the 
preparation of the HAS-Zein dispersions) overnight using a magnetic stirrer. 
2.3 Preparation of Free Films 
Zein alone, HAS alone and HAS/Zein dispersions were prepared as described in 
Section 2.2. Free films were prepared by a casting/solvent evaporation technique, as 
described in the work of Gillgren et al. (Gillgren et al., 2009). The aqueous dispersions 
(9 g each) were poured onto 90 mm plastic petri dishes and dried in an oven at 45 ± 
5 °C for 24 hours. After drying, the films were stored in a desiccator over P2O5 (0 % 
RH) at room temperature for subsequent studies.  
 
 
  
 
2.4 Characterization of Free Films 
2.4.1 Scanning Electron Microscopy (SEM) 
The surface morphology of zein alone and HAS/Zein free films as well as morphology 
of coated tablets were studied using SEM. Samples were mounted onto stubs using 
double-sided tape and were gold coated by a Polaron SC7640 sputter gold coater 
manufactured by Quorum Technologies (UK). The thickness of the gold coating was 
about 15 nm. The imaging process was performed in a high vacuum environment with 
a JEOL JSM5900 LV SEM (Japan), mounted with a tungsten filament with an 
acceleration voltage of 5-20 kV. 
 
2.4.2 Nano-Localized Thermal Analysis (n-LTA) 
Topographic images were acquired with a Caliber atomic force microscope (AFM) 
from Bruker AFM (UK) equipped with an AN-200 Thermalever probe from Anasys 
instruments (USA). The scan area for all AFM images was 50 µm x 50 µm with a 
resolution of 512 pixels and a scan rate of 0.5 Hz. Localized thermal analysis was 
carried out using the same system as described above but equipped with a nanoTA2 
controller (Anasys Instruments, USA). A typical measurement is carried out by 
generating a topographical image of the film surface using the AFM and then selecting 
a point on the surface for interrogation. A voltage is then applied to the probe by the 
nanoTA2 controller and the deflection of the probe monitored. As the probe heats the 
material directly beneath the probe, the material expands, forcing an upward deflection 
of the probe. As the temperature reaches a thermal transition such as a melting point, 
the material softens and the probe penetrates into the surface. At this point the 
temperature profile is stopped and the probe retracted. Measurements were carried 
over a range of room temperature to 200 °C at a heating rate of 10 °C/s. 
 
2.4.3 Attenuated Total Reflectance Fourier Transform Infra-Red (ATR-FTIR) 
Fourier-transform infrared (FTIR) measurements were carried out in attenuated total 
reflectance (ATR) mode. The infrared spectra of the samples were collected using a 
Bruker IFS 66/S spectrophotometer (Bruker Optics Ltd., UK), fitted with a Golden Gate 
  
 
ATR accessory from Specac Ltd. (UK). Measurements were carried out over a spectral 
range of 4,000 to 550 cm−1 with a total of 16 scans acquired at a resolution of 4 cm−1. 
2.5 Preparation and Film Coating of Paracetamol-Loaded Tablets 
The formulation was produced via wet granulation as described in Table 1. The 
granules were loaded onto a Manesty E-2 single station tablet press (Manesty 
Machines Ltd., UK) and were compressed using round 7 mm diameter plain, normal 
concave punches. Tablet specifications tests including weight uniformity, content 
uniformity and tablet thickness were determined (Table 1). Hardness was measured 
using an Erweka TBH 28 hardness tester (Germany) and friability was determined 
using Erweka TAR friabilator (Germany) at 100 rotations. The disintegration time was 
measured in distilled water and in 0.1 M HCl at 37 ± 0.5 ºC in a Copley DTG 2000 
apparatus using disks (UK).  
Coating was performed on ten tablets batches using a top-spray fluidized-bed coater 
(Mini Coater/Drier 2, Caleva Process Solutions Ltd, UK). The coating was carried out 
in a bed temperature of 45 °C, atomization pressure of 0.7 bar, pump rate of 1.09 rpm 
and fan speed of 13 to 13.5 m/s. A drying stage was incorporated into the process by 
turning off the spray and keeping the coated tablets at the same bed temperature for 
15 minutes. The tablets were then cured in an oven for 10 hours at 45 °C. The film 
thickness is expressed in terms of the percentage total weight gain (TWG), and tablets 
with a TWG of 20% were obtained. 
2.6 In Vitro Drug Release Studies 
Dissolution studies were carried out on a Copley CIS 8000 dissolution bath (Copley 
Scientific, UK) with a rotation speed of 50 rpm according to the BP Apparatus I basket 
method. The tests were performed in 900 mL of freshly prepared simulated gastric 
fluid (SGF, 2 g L-1 NaCl, 3.2 g L-1 pepsin, 80 mL L-1 1M HCl (BP 2011)) pH 1.2 for 2 
hours at 37 ± 0.5 °C, followed by 6 hours in freshly prepared simulated intestinal fluid 
(SIF, 6.8 g L−1 KH2HPO4, 10 g L−1 pancreatin, 77 mL L-1 0.2 M NaOH (BP 2011)) pH 
6.8. Samples of 10 mL were withdrawn at predetermined times, filtered through a 0.2 
μm membrane filter (Sartorius Stedim Biotech GmbH, Germany) and replaced with an 
equivalent volume of fresh medium. The paracetamol concentration was determined 
spectrophotometrically (Lambda XLS UV/VIS, Perkin-Elmer, USA) at a wavelength of 
243 nm and with reference to an appropriate standard curve. Samples that contained 
  
 
the pancreatic digestive enzymes were centrifuged at 13,000 rpm for 30 minutes prior 
to filtration and UV measurements. The dissolution studies were carried out in triplicate 
and the average drug release ± SD was calculated.  
 
2.7 Batch Culture Fermentation studies 
Drug release from the tablets was also assessed under simulated colonic conditions 
using a batch fermentation system. Fermenters consisted of glass bottles, fitted with 
the standard dissolution baskets and a magnetic stirrer. The vessels were filled with 
prereduced basal culture medium, prepared based on work of Hughes et al. (Hughes 
et al., 2008). This medium contained per litre: 2 g peptone water (Oxoid Ltd., UK), 2 g 
yeast extract (Oxoid), 0.1 g NaCl, 0.04 g K2HPO4, 0.01 g MgSO4.7H2O, 0.01 g 
CaCl2.6H2O, 2 g NaHCO3, 0.005 g haemin (Sigma), 0.5 g L-cysteine HCl (Sigma), 0.5 
g bile salts (Oxoid), 2 mL Tween 80, 10 μL vitamin K (Sigma), and 4 mL of 0.025% 
(w/v) resazurin solution. The fermenters were then inoculated with a 10% (w/w) faecal 
slurry which was prepared by homogenizing fresh human faeces and prereduced 
phosphate-buffered saline (PBS 8 g L−1 NaCl, 0.2 g L−1 KCl, 1.15 g L−1 Na2HPO4, and 
0.2 g L−1 KH2HPO4) pH 7.3, in a Stomacher 400 (Seward, UK) at 230 rpm for 45 s. 
Unhomogenized fibrous material was removed by filtration through filter bags 
(Stomacher® lab system, BA6141/STR bag filters made for Seward LTd.). The final 
pH was adjusted to 6.8. The tablets were placed in the dissolution baskets, then 
introduced into 100-mL batch culture fermenters and stirred using a magnetic flea at 
100 rpm for 24 hours. All additions, inoculations and incubations were carried out 
inside an anaerobic cabinet (10% H2, 10% CO2, and 80% N2) at 37 °C. Control 
experiments using autoclaved faecal sample (i.e. dead bacterial cells and no 
enzymatic activity) were run on a subsequent day. Experiments were conducted in 
triplicate. 
One-mL samples were removed at predetermined times over a 24-hour period, 
centrifuged at 14,000 rpm for 10 minutes, and filtered through 0.2 µ m filters prior to 
analysis for paracetamol by high-performance liquid chromatography (HPLC; Dionex, 
UK). The mobile phase consisted of acetonitrile (MeCN)-water (25:75 v/v) adjusted to 
pH 2.5 with phosphoric acid and pumped at 1.7 mL.min-1 through a C18, 5 µm, 250 x 
4.6 mm column (Phenomenex, UK). UV detection was carried out at 245 nm. 
  
 
3. Results and Discussion  
3.1 Characterization of Free Films  
SEM and AFM images of the surfaces of the free films were obtained to gain 
information regarding the miscibility of the two polymers and overall quality of the films. 
SEM images of the surfaces obtained using different HAS and zein ratios (w/w) are 
presented in Figure 1. The acetylated high amylose maize starch (HAS) alone film 
(Figure 1a) showed granular structures of non-uniform architecture. The swelling of 
starch granules upon heat treatment at 80 °C, as reported by Freire et al. (Freire et 
al., 2009a) could possibly explain the formation of these granular structures; the same 
group (Freire et al., 2009b) reported similar results using a starch type with 
approximately the same amylose content to the one used in this study. The authors 
stated that despite the intense swelling of starch granules, most of the granules did 
not burst and formed aggregates at the surface of the free films. The zein alone film 
(Figure 1b) had a compact surface made up of smaller spherical particles. Similar 
structures were observed by Li et al. (Li et al., 2010). The 1:7 and 1:5 HAS/Zein films 
(Figure 1c and d) showed a smooth surface along with some spherical features similar 
to those observed with zein alone films. The 1:3 HAS/Zein film had a smooth and 
homogenous surface (Figure 1e), in contrast to that observed with films of lower 
HAS/Zein ratios. These images therefore suggest that a more homogenous dispersion 
of the two phases occurred at higher HAS/Zein ratios. This may be associated with 
the adhesion between zein and starch as proposed by Habeych et al. (Habeych et al., 
2008), who suggested that increasing zein concentration promoted poorer adhesion 
between the components, which is in keeping with the observations made here. 
 
AFM topographic images were also acquired to identify surface features of the films 
(Figure 2_A), and were in alignment with the SEM images (Figure 1). HAS alone free 
film exhibited large circular features, similar to those seen in SEM images, while the 
surface of zein alone film was made up of smaller spherical particles. This is in 
agreement with Li et al. (Li et al., 2010) who reported that the plasticized zein films 
prepared from aqueous dispersion were more compact, smoother and composed of 
smaller colloidal particles compared to the plasticized films prepared form organic 
solutions. HAS/Zein films showed different structural patterns which were intermediate 
between the features displayed by the single components and were dependent on the 
  
 
HAS/Zein ratio of the film. Films having the lowest HAS/Zein ratio, i.e. 1:7 showed 
mainly spherical particles. Films with the highest ratio, i.e. 1:3 had the smoothest 
surface (height difference = 400 nm) and those of 1:5 ratio were made up of spherical 
particles along with smoother areas. Again, these results might suggest a poor 
adhesion between the two polymers at lower HAS/Zein ratios compared to the higher 
ratios.  
 
To determine the nature of the different structures observed in the topographic images 
of the film surface, single point LTA measurements were carried out at various 
locations on the film surface. This technique consists of the application of a heated 
nanoprobe onto a surface and the measurement of the position of the probe as a 
function of temperature; more details can be found in (Craig et al., 2002). Each 
individual measurement has a scale of scrutiny of circa 500nm by 500nm.  Figure 2_B 
shows the corresponding LTA responses. Whilst HAS alone films showed no 
measurable transitions up to degradation (and hence is not included in Figure 2B), 
zein alone films were relatively consistent with softening occurring at 75.7 ± 5.3 °C; 
this softening temperature is related to the glass transition of zein. HAS/Zein films of 
1:7, 1:5 and 1:3 ratios showed a trend whereby one softening point, in most cases, 
was detected at circa 115.7 ± 3.8, 135.9 ± 6.6 and 142.2 ± 10.4 °C, respectively. It is 
worth noting that although the topographic images of film surface were 
inhomogeneous, particularly at lower HAS/Zein ratios, only one softening transition 
was detected in the corresponding LTA measurements. Chanvrier et al. (Chanvrier et 
al., 2005) reported that although starch and zein are immiscible, only one thermal 
transition was detected, possibly because the peaks due to the main relaxation of 
starch and zein were superimposed. Indeed, Chanvrier et al. (Chanvrier et al., 2006) 
found that starch and zein have similar Tg values and thus deduced that the transitions 
measured on the starch-zein blends corresponds to the superimposition of the glass 
transition of each component. However, it should be also noted that the softening 
temperature detected by LTA increased with increasing the HAS/Zein ratio, i.e. with 
the addition of starch. This type of behaviour might indicate that some physical 
interactions between zein particles and starch granules occurred at the interaction 
surface between the components. This result is not in keeping with the findings of 
(Chanvrier et al., 2006; Corradini et al., 2007) , where the transition temperatures of 
immiscible blends remained nearly constant for all starch-zein ratios. This may reflect 
  
 
the differing nature of the measurements; nanothermal analysis measures the 
temperature of physical softening rather than the associated thermodynamic event, 
hence the differences may reflect the manner in which the starch is altering the 
thermomechanical properties of the films.    
 
Moreover, FT-IR spectra of the mixed films with various HAS/Zein ratios were obtained 
in the spectral region of 4000 to 500 cm-1 to investigate any possible interactions 
between the two polymers (Figure 3); HAS alone and zein alone films were scanned 
for comparison. The FTIR spectrum of zein protein consists of the typical protein bands 
including amide І from 1750 to 1600 cm-1 and amide ІІ from 1500 to 1400 cm-1 (Forato 
et al., 2003). HAS alone film showed distinct peaks at 1005 cm-1, 1080 cm-1 and 1153 
cm-1 in addition to a small peak at 1240 cm-1 which is typical of acetylated starches. 
No spectra of the mixed HAS/Zein films, regardless of the ratio, exhibited any 
significant shifts in the amide I and II peaks and no new peaks could be detected even 
at the highest HAS content, suggesting a lack of chemical interaction between the two 
polymers. 
 
Overall, SEM and AFM images indicate that starch/zein films were morphologically 
inhomogeneous, particularly at lower starch/zein ratios. However, the NTA 
measurements did not indicate distinct transition populations, a characteristic of 
systems that are homogeneous at the scale of scrutiny (circa 500nm by 500nm) hence 
at least some of the topographic inhomogeneity noted may reflect architectural rather 
than compositional distribution. It is also interesting to note the increase in the 
measured softening temperature as the HAS/Zein ratio increased, reflecting the 
changes in thermoresponsive behaviour as the composition is altered.  This again is 
a typical characteristic of blended systems.     
 
3.2 Paracetamol Release Profile from Tablets Film Coated with Starch-Zein 
Dispersions 
3.2.1 Effect of Starch to Zein Ratio on Paracetamol Release  
Paracetamol tablets were coated with HAS/Zein aqueous based coatings of different 
compositions to a TWG of 20%. The effect of starch to zein ratio on paracetamol 
  
 
release is shown in Figure 4. The test was carried out under acidic conditions in order 
to maximally challenge the formulation, as the dibasic calcium phosphate within the 
tablet core is soluble in dilute acids, potentially exerting an osmotic pressure against 
the coating after dissolution of (at least part of) the tablet core. Drug release from zein 
alone and 1:5 HAS/Zein coatings was comparable. Increasing the starch content in 
film coatings increased the drug release rate and extent in comparison to coatings with 
no or less starch. We suggest that the drug release through zein-based coatings 
occurs mainly via diffusion and increasing the hydrophilic content in the water insoluble 
film coat will influence the drug release. The swelling of starch in aqueous 
environments will disrupt the structure of the film and create aqueous channels 
through which more drug release can occur (Siew et al., 2000). The results of drug 
release also suggest that the water insoluble zein domains could control the swelling 
of starch only at lower starch concentration, whereas rupture of the film coating 
occurred at the higher ratio, i.e. 1:3. Similarly, reducing the coating thickness of the 
1:5 HAS/Zein ratio to a TWG of 10% resulted in film rupture and premature drug 
release in the upper GIT (Figure S1). Thus, formulations with 1:5 HAS/Zein ratio 
coated to a TWG of 20% were used for further investigations. 
 
3.2.2 Paracetamol Release in Simulated Gastric and Intestinal Fluids 
A key requirement of a colonic-targetted drug delivery system is to minimize early drug 
release in the upper gastrointestinal tract (Basit, 2005). To investigate this, zein alone 
and 1:5 HAS/Zein coated tablets were tested in conditions simulating the stomach and 
the small intestine. The drug release profiles from zein alone and 1:5 HAS/Zein coated 
formulations in simulated gastric fluid with pepsin (SGF with pepsin) for 2 hours and 
subsequently in simulated intestinal fluid with pancreatin (SIF with pancreatin) for a 
further 6 hours are shown in Figure 5. Approximately, 12% and 14% of the drug was 
released after 6 hours, respectively. The release profile of HAS/Zein based coatings 
was very similar to that of zein alone, suggesting that the starch present in the films is 
resistant to digestion by the enzymes present in SGF and SIF, at least over this test 
duration chosen to reflect the average transit time of solid dosage forms in the stomach 
(2 hours) and small intestine (4 hours) (Yang, 2008).  
 
  
 
The values of % drug release obtained here were comparable to those obtained with 
pectin/zein complex hydrogel beads in environments similar to the stomach and small 
intestines (Liu et al., 2006). However, these values were higher in comparison to those 
obtained for ethyl cellulose-based films (Freire et al., 2009b; Siew et al., 2000). This 
difference could be explained by the fact that although zein, like ethyl cellulose, is 
water insoluble, it swells in the presence of an aqueous medium (Berardi et al., 2017a, 
2017b), thus increasing the porosity and permeability of the coating. The difference in 
release can also be attributed to differences in the formulation of the core substrate 
and drug used. Nevertheless, the drug release under conditions simulating the upper 
GIT suggests that high amylose maize starch-based films can be used potentially for 
colon-specific delivery.  
 
3.2.3 Paracetamol Release in Simulated Colonic Fluids Using a Batch Culture 
Fermentation System 
The dissolution testing explained above provided information about the resistance of 
the coating to drug release under conditions resembling those of the upper 
gastrointestinal tract. In this section, the susceptibility of pseudolatex-based zein alone 
and HAS/Zein coatings to digestion by the colonic microbiota was investigated using 
a batch culture fermentation system inoculated with human faecal bacteria. Figure 6 
shows the paracetamol release from zein alone and 1:5 HAS/zein coated tablets under 
colonic (with faecal content) and control (with autoclaved faecal content) conditions.  
 
For both formulations, the drug release in simulated colonic conditions (solid-lines) 
was greater than in the control conditions (dashed-lines), indicating that both systems 
are being subjected to digestion by the gut microbiota. It is interesting to note the 
following.  Firstly, the difference in profiles between the zein alone and the HSA/zein 
coated systems was greater for the batch culture fermentation system than for the in 
vitro study shown in Figure 5.  Secondly, in both cases release under the colonic 
conditions was more rapid than the control, the difference being greater for the 
HSA/zein systems. Taken together, the results indicate that there are multiple 
influences in operation within the simulated colonic environment. The composition of 
the fermentation study media, irrespective of autoclaving, compared to the in vitro 
study shown in Figure 5, does appear to influence the release, possibly by solubilising 
  
 
or by modifying the swelling behaviour of the film components which may promote 
release from zein-based systems. Thirdly, there is indeed evidence (i.e. the greater 
release compared to the control) that the presence of the HSA increases the release 
via digestion by the microbiota (the difference is statistically significant (p<0.05)), 
hence the hypothesis on which the study has been based is supported. Further 
optimisation of the formulation may increase the difference between the HSA loaded 
and unloaded coats, particularly given that the level of starch present was relatively 
low.  Perhaps surprisingly, there is some evidence of the zein also being digested by 
the microbiota, probably reflecting the presence of bacterial proteases in the colon 
model system. Nevertheless, overall the fermentation study has demonstrated that the 
presence of HSA may render the coats susceptible to digestion by colonic bacteria.   
 
The question arises as to the likely relationship to the in vivo situation, particularly 
amongst the ulcerative colitis patient population.  It has been reported that the total 
colonic transit time in individuals with ulcerative colitis is on average 24.3 hours as 
opposed to 51.7 hours in healthy individuals (Hatton et al., 2018; Hebden et al., 2001); 
This makes the formulation developed here potentially suitable to orally deliver the 
entire drug payload to the diseased colon despite the reduced residence time. 
 
SEM images of the surface of tablets coated with zein alone and 1:5 HAS/Zein after 
24 hours in control and colonic conditions are shown in Figure 7. The zein coated 
tablet had a fairly smooth surface before the release study (a), but showed signs of 
extensive digestion under colonic conditions (c), compared to the control (b) 
conditions. More significantly, tablets coated with HAS/Zein (Figure 7, lower row) 
showed a complete loss of the coating structure and integrity under colonic conditions 
(c), whereas the coating was highly porous under control conditions (b). 
 
The release of paracetamol from zein alone or HAS/Zein coated tablets is postulated 
to occur mainly via drug diffusion through the aqueous channels formed either by the 
spaces between the polymeric chains or by the dissolution of some film ingredients 
along with some erosion and/or degradation of the polymeric membrane in the 
presence of digestive enzymes.. Pre-existing microcracks are also a possibility but the 
thickness of the coat and the absence of evidence of such structures from SEM may 
render this mechanism less likely; however crack generation on swelling is also 
  
 
feasible.  
 
Although macroscopically zein alone coatings remained intact after 24 hours exposure 
to the colonic media, SEM images indicated a degree of surface erosion (Figure 7, 
upper row_ c). The fact that these polymeric coatings retained their structural integrity 
further suggests that these coated systems are primarily diffusion-controlled, with the 
exception of HAS/Zein tablets that showed a complete loss of the coating structure 
under colonic conditions (Figure 7, lower row_ c). While further optimisation in terms 
of, for example, coating thickness and HSA content is necessary to bring this approach 
to a pre-clinical stage, the investigation here nevertheless indicates that the principle 
of using HSA-loaded zein coatings is a promising approach for selective delivery to 
the colon.  
 
4. Conclusions 
 
The present work has examined the use of high amylose maize starch (HAS) and zein 
film coatings as potential vehicles for colon-specific drug delivery. HAS/Zein free films 
showed no evidence for phase separation or chemical interaction between the two 
polymers. Both zein alone and 1:5 HAS/Zein coated tablets showed limited drug 
release under upper gastrointestinal tract conditions, indicating that the starch resisted 
digestion by pepsin and pancreatin enzymes and that zein effectively suppressed the 
swelling of starch and the consequent drug release. Under colonic conditions, the drug 
release from 1:5 HAS/Zein was complete and significantly (p < 0.05) higher than zein 
coated tablets, suggesting that the starch in this film was susceptible to digestion by 
the colonic microbiota. The drug delivery device for colonic-specific targeting 
described here is thus promising and provides a robust drug delivery platform that 
could be further engineered to tailor drug release profiles to specific needs. 
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Figure captions 
 
Figure 1 SEM images of free films surface of (a) HAS alone, (b) zein alone, (c) 1:7 
HAS/Zein, (d) 1:5 HAS/Zein and (e) 1:3 HAS/Zein films.  
 
Figure 2 (A) AFM topographic images and (B) corresponding LTA measurements of 
(a) HAS alone (b) zein alone (c) 1:7 HAS/Zein (d) 1:5 HAS/Zein and (e)1:3 HAS/Zein 
free films.   
 
Figure 3 FT-IR spectra of zein alone film, HAS alone film, and 1:7, 1:5 and 1:3 
HAS/Zein films in the spectral region of 500 to 4000 cm-1. 
 
Figure 4 Dissolution profiles in 0.1 M HCl of paracetamol tablets coated (TWG = 20%) 
with zein alone, 1:5 HAS/Zein and 1:3 HAS/Zein pseudolatexes. Each point represents 
the mean value ± SD (n = 3).  
 
Figure 5 Dissolution profiles of paracetamol tablets coated (TWG = 20%) with zein 
pseudolatex alone and 1:5 HAS/Zein pseudolatex in SGF (with pepsin) pH 1.2 (2 
hours) then SIF (with pancreatin) pH 6.8 (6 hours). Each point represents the mean 
value ± SD (n = 3). (Error bars within data points). 
 
Figure 6 Release profile of paracetamol from tablets coated (TWG = 20%) with zein 
alone (black lines) and 1:5 HAS/Zein dispersions (red lines) in colonic (solid lines) and 
control (dashed lines) conditions. Each point represents the mean ± SD (n = 3). 
 
Figure 7 SEM images of paracetamol tablets coated with zein alone (upper row) and 
tablets coated with 1:5 HAS/Zein (lower row) aqueous dispersions: prior to any 
treatment (a); and after 24 hours immersion in: control (b); and colonic (c) conditions. 
 
 
 
 
 
 
 
  
 
Table 1 Formulation and specification tests data for paracetamol-loaded tablets. 
 
Chemical  Content 
(g)/batch 
Specification 
test 
Mean  
(SD) 
Calcium 
phosphate 
dibasic 
423.75 Weight uniformity 
(mg, n = 20) 
212.7 
(2.5) 
Paracetamol 150.00 Content 
uniformity 
(mg, n = 10) 
43.3  
(0.9) 
MCC 75.00 Thickness 
(mm, n= 20)  
3.9 
(0.03) 
PVP * 18.75 Hardness 
(kp, n = 20)  
12.0  
(1.0) 
Partially 
gelatinized starch 
75.00 Disintegration 
time 
(minutes, n = 6): 
 
Water  As 
required 
In water  1.78  
(0.4) 
Magnesium 
stearate  
7.50 In 0.1 M HCl 0.8  
(0.3) 
Total 750.00 g   
*Added as 100 mL of 18.75% aqueous solution during granulation. 
 
 
  
  
  
  
  
  
  
  
